Search Within

Molecular Imaging and Therapy Service

Formats
  1. Journal Article (1834)
  2. Meeting Abstract (941)
  3. Book Section (179)
  4. Review (161)
  5. Editorial (46)
  6. Conference Paper (40)
  7. Guidelines (32)
  8. Miscellaneous (19)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (7)
Groups
  1. Radiology, Department of (3104)
  2. GSK Faculty (1491)
  3. Sloan Kettering Institute Faculty (1250)
  4. Molecular Pharmacology and Chemistry Program Faculty (1235)
  5. Department of Medicine (1003)
  6. Sloan Kettering Institute Postdocs (885)

More Groups

People
  1. Steven Larson (962)
  2. Heiko Schoder (555)
  3. Neeta Pandit-Taskar (348)
  4. John Humm (284)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (211)

More People

Years
  1. 2025 (76)
  2. 2024 (134)
  3. 2023 (176)
  4. 2022 (176)
  5. 2021 (200)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (577)
  2. Journal of Clinical Oncology (251)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (102)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (577)
  2. Springer (435)
  3. Elsevier Inc. (286)
  4. American Society of Clinical Oncology (263)
  5. Lippincott Williams & Wilkins (155)
  6. American Association for Cancer Research (151)

More Publishers

Results (3282)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GT3-Nano based radioprotector drug promotes rapid recovery from (153)Sm-EDTMP induced myelotoxcity
    Meeting Abstract

    Lee, S. G.; Kalidindi, T. M.; Punzalan, B.; Pillarsetty, N.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Multicycle pretargeted radioimmunotherapy using 177(Lu) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; Punzalan, B.; Veach, D.; Xu, H.; Guo, H. F.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted radioimmunotherapy using 225(Ac) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; McDevitt, M.; Xu, H.; Guo, H. F.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted alpha radioimmunotherapy (DOTA-PRIT) for HER2-expressing human gastric cancer: A theranostic approach using 111(In)/225(Ac)-radiohapten
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • (225)Ac-alpha pretargeted radioimmunotherapy (DOTA-PRIT) of human colorectal cancer: Achieving 100% complete responses with single-cycle targeting of 2 distinct antigens, HER2 and GPA33
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Prediction of long-term overall survival using quantification of myocardial flow reserve in cancer patients referred for clinical 82-rubidium PET perfusion imaging
    Meeting Abstract

    Ito, K.; Fox, J.; Dipti, G.; Schoder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Kelly, C. M.; Kiesler, H.; Martindale, M.; Nicholls, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A blood-based multi-mRNA liquid biopsy with > 90% accuracy for diagnosis and assessment of prostate cancers
    Meeting Abstract

    Rahbar, K.; Kidd, M. S.; Drozdov, I. A.; Kitz, A.; Malczewska, A.; Rajwa, P.; Boegemann, M.; Bernemann, C.; Bodei, L.; Modlin, I. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I/II study of SAR439859, an oral selective estrogen receptor degrader (SERD), in estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC)
    Meeting Abstract

    Campone, M.; Bardia, A.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Pelekanou, V.; Celanovic, M.; Linden, H. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save